Metraipolis › archive › dc_c8e2ad10ee43
Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42195263
- DOI
- 10.3390/life16050708
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T07:32:22.887Z
- SHA-256 of the archived text
df4db27a5e41f346ce0bb5b99a60eab8557973b714988c96dc18c3e8d1b51a3e- Stable URL of this page
https://metraipolis.com/documento/dc_c8e2ad10ee43
How to cite
Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263 — Europe PMC (en), https://europepmc.org/article/MED/42195263 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c8e2ad10ee43 (Metraipolis archive dc_c8e2ad10ee43, sha256 df4db27a5e41f346ce0bb5b99a60eab8557973b714988c96dc18c3e8d1b51a3e)
BibTeX
@misc{dcc8e2ad10ee43,
title = {Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study — Europe PMC PMID:42195263},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42195263},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c8e2ad10ee43; sha256 df4db27a5e41f346ce0bb5b99a60eab8557973b714988c96dc18c3e8d1b51a3e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195263. Agents can read the archived copy with the MCP tool read_document.